Having memory problems or trouble thinking clearly?

If this sounds like you, or someone you know, please consider the EMERGE Study.

Having memory problems or trouble thinking clearly? If this sounds like you, or someone you know, please consider the EMERGE Study.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Alzheimer's Disease Clinical Trial in Gatineau Quebec
NCT02484547 | Phase 3 | Interventional

What you may receive

Compensation of $100 per visit for xx visits

Biogen
Sponsored by
Biogen

Having memory problems or trouble thinking clearly?

If this sounds like you, or someone you know, please consider the EMERGE Study.

Having memory problems or trouble thinking clearly? If this sounds like you, or someone you know, please consider the EMERGE Study.

Terminated

Male & Female

50 - 85

Years old

This study has recruited 1643 Participants

The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with early AD. Secondary objectives are to assess the effect of monthly doses of aducanumab as compared with placebo on clinical progression as measured by Mini-Mental State Examination (MMSE), AD Assessment Scale-Cognitive Subscale (13 items) [ADAS-Cog 13], and AD Cooperative Study-Activities of Daily Living Inventory (Mild Cognitive Impairment version) [ADCS-ADL-MCI].

Why should I participate?

The EMERGE Study is a global study assessing the efficacy and safety of an investigational medication, to determine whether it can slow the progression of symptoms in early Alzheimer’s disease.

There is an important medical and scientific need to research therapies that could delay memory loss and the progression of disability in Alzheimer’s disease because there are currently no approved treatments that slow the course of the condition.

What's involved?

You will need a study partner – someone who is close to you, such as a family member or close friend – to attend certain study visits with you and provide information on your health and well-being.If eligible, all study medication, examinations, and medical care related to the study will be provided at no cost to you. Reasonable compensation for time and travel may be provided.

Who can participate?

You may be able to take part in the EMERGE Study if you are 50 –85 years of age and are experiencing symptoms that might be related to early Alzheimer’s disease, such as problems with memory or thinking clearly.